WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Related articles:
Related suggestion:
All England Open: Zheng/Huang retain mixed doubles titleWang Shanshan Named Chinese Women's Footballer of the YearInheriting Craft Helps Woman Promote Hometown's RevitalizationChina Claims Women's Team Title at Asian Table Tennis ChampionshipsDAILY MAIL COMMENT: Israel must beware allChina's Yin Ruoning Wins Women's PGA ChampionshipYoung Chinese Woman Aerobatic Pilot Fulfills Flying Dreams Overseas in AustraliaSteel Roses Look to BloomChina's Zuo Wins Women's AllCanada and U.S. ratchet up their cross
2.3373s , 6495.1953125 kb
Copyright © 2024 Powered by FDA brings lab tests under federal oversight in bid to improve accuracy and safety ,Global Gatherings news portal